The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine

NCT05056519 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza Prevention

Interventions

BIOLOGICAL: Live Attenuated Influenza Vaccine
BIOLOGICAL: Live Attenuated Influenza Vaccine placebo

Sponsor

Changchun BCHT Biotechnology Co.

Collaborators

[object Object]